section name header

References

  1. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-2100 PMID: 15882252 doi:10.1111/j.1523-1755.2005.00365.x
  2. Nelms CL, Shaw V, Greenbaum LA, et al. Assessment of nutritional status in children with kidney diseases-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021;36(4):995-1010 PMID: 33319327 doi:10.1007/s00467-020-04852-5
  3. Shaw V, Polderman N, Renken-Terhaerdt J, et al. Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2020;35(3):519-531 PMID: 31845057 doi:10.1007/s00467-019-04426-0
  4. Rees L, Shaw V, Qizalbash L, et al; Pediatric Renal Nutrition Taskforce. Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021;36(1):187-204 PMID: 32728841 doi:10.1007/s00467-020-04623-2
  5. Spivacow FR, del Valle EE, Boailchuk JA, Diaz S, et al. Metabolic risk factors in children with kidney stone disease: an update. Pediatr Nephrol. 2020: 35(110: 2107-2112
  6. Sas DJ. Dietary risk factors for urinary stones in children. Curr Opin Pediatr. 2020;32(2):284-287 PMID: 32068596 doi:10.1097/MOP.0000000000000886
  7. Goka SQ, Copelovitch L. Prevention of recurrent urinary stone disease. Curr Opin Pediatr. 2020;32(2):295-299 PMID: 31790032 doi:10.1097/MOP.0000000000000852
  8. Demoulin N, Aydin S, Gillion V, Morelle J, Jadoul M. Pathophysiology and management of hyperoxaluria and oxalate nephropathy: a review. Am J Kidney Dis. 2022;79(5):717-727 PMID: 34508834 doi:10.1053/j.ajkd.2021.07.018
  9. Litwin M, Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol. 2021;36(4):825-837 PMID: 32388582 doi:10.1007/s00467-020-04579-3
  10. Rutigliano I, De Filippo G, Pastore L, Messina G, Agostoni C, Campanozzi A. Obesity-related hypertension in pediatrics, the impact of American Academy of Pediatrics guidelines. Nutrients. 2021;13(8):2586 PMID: 34444745 doi:10.3390/nu13082586
  11. Natsis M, Antza C, Doundoulakis I, Stabouli S, Kotsis V. Hypertension in obesity: novel insights. Curr Hypertens Rev. 2020;16(1):30-36 PMID: 30987571
  12. Mollerup PM, Lausten-Thomsen U, Fonvig CE, Baker JL, Holm JC. Reductions in blood pressure during a community-based overweight and obesity treatment in children and adolescents with prehypertension and hypertension. J Hum Hypertens. 2017;31(10):640-646 PMID: 28492239 doi:10.1038/jhh.2017.36
  13. Gartlehner G, Vander Schaaf EB, Orr C, Kennedy SM, Clark R, Viswanathan M. Screening for hypertension in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020;324(18):1884-1895 PMID: 33170247 doi:10.1001/jama.2020.11119
  14. Lari A, Sohouli MH, Fatahi S, et al. The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(10):2766-2778 PMID: 34353704 doi:10.1016/j.numecd.2021.05.030
  15. Cohen JFW, Lehnerd ME, Houser RF, Rimm EB. Dietary approaches to stop hypertension diet, weight status, and blood pressure among children and adolescents: National Health and Nutrition Examination Surveys 2003-2012. J Acad Nutr Diet. 2017;117(9):1437-1444.e2 PMID: 28539258 doi:10.1016/j.jand.2017.03.026
  16. Zafarmand MH, Spanjer M, Nicolaou M, et al. Influence of dietary approaches to stop hypertension-type diet, known genetic variants and their interplay on blood pressure in early childhood: ABCD study. Hypertension. 2020;75(1):59-70 PMID: 31786974 doi:10.1161/HYPERTENSIONAHA.118.12292
  17. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346(apr03 3):f1325 PMID: 23558162 doi:10.1136/bmj.f1325
  18. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346(apr03 3):f1326 PMID: 23558163 doi:10.1136/bmj.f1326
  19. Rios-Leyvraz M, Bloetzer C, Chatelan A, et al. Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta-analysis. J Clin Hypertens (Greenwich). 2019;21(1):118-126 PMID: 30489016 doi:10.1111/jch.13436
  20. Overwyk KJ, Zhao L, Zhang Z, Wiltz JL, Dunford EK, Cogswell ME. Trends in blood pressure and usual dietary sodium intake among children and adolescents, National Health and Nutrition Examination Survey 2003 to 2016. Hypertension. 2019;74(2):260-266 PMID: 31230545 doi:10.1161/HYPERTENSIONAHA.118.12844
  21. National Academies of Sciences. Engineering, Medicine. Dietary Reference Intakes for Sodium and Potassium, March 2019 www.nationalacademies.org/hmd/Reports/2019/dietary-reference-intakes-sodium-potassium.aspx
  22. Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition management. Nutr Clin Pract. 2021;36(2):331-343 PMID: 33469930 doi:10.1002/ncp.10622
  23. Hari P, Khandelwal P, Smoyer WE. Dyslipidemia and cardiovascular health in childhood nephrotic syndrome. Pediatr Nephrol. 2020;35(9):1601-1619 PMID: 31302760 doi:10.1007/s00467-019-04301-y
  24. Pennisi A, Maranda B, Benoist JF, et al. Nocturnal enteral nutrition is therapeutic for growth failure in Fanconi-Bickel syndrome. J Inherit Metab Dis. 2020;43(3):540-548 PMID: 31816104 doi:10.1002/jimd.12203
  25. Francini F, Gobbi L, Ravarotto V, et al. The dietary approach to the treatment of the rare genetic tubulopathies Gitelman's and Bartter's Syndromes. Nutrients. 2021;13(9):13 PMID: 34578838 doi:10.3390/nu13092960
  26. Gambaro G, Croppi E, Coe F, et al; Consensus Conference Group. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29(6):715-734 PMID: 27456839 doi:10.1007/s40620-016-0329-y
  27. D'Alessandri-Silva C, Carpenter M, Mahan JD. Treatment regimens by pediatric nephrologists in children with congenital nephrogenic diabetes insipidus: A MWPNC study. Clin Nephrol. 2018;89(5):358-363 PMID: 29162216 doi:10.5414/CN109127
  28. Khor BH, Tiong HC, Tan SC, Abdul Rahman R, Abdul Gafor AH. Protein-energy wasting assessment and clinical outcomes in patients with acute kidney injury: a systematic review with meta-analysis. Nutrients. 2020;12(9):2809 PMID: 32933198 doi:10.3390/nu12092809
  29. Meyer D, Mohan A, Subev E, Sarav M, Sturgill D. Acute kidney injury incidence in hospitalized patients and implications for nutrition support. Nutr Clin Pract. 2020;35(6):987-1000 PMID: 33140897 doi:10.1002/ncp.10595
  30. Sabatino A, Regolisti G, Maggiore U, Fiaccadori E. Protein/energy debt in critically ill children in the pediatric intensive care unit: acute kidney injury as a major risk factor. J Ren Nutr. 2014;24(4):209-218 PMID: 24216255 doi:10.1053/j.jrn.2013.08.007
  31. Kyle UG, Akcan-Arikan A, Silva JC, Goldsworthy M, Shekerdemian LS, Coss-Bu JA. Protein feeding in pediatric acute kidney injury is not associated with a delay in renal recovery. J Ren Nutr. 2017;27(1):8-15 PMID: 27838192 doi:10.1053/j.jrn.2016.09.009
  32. McCarthy MS, Phipps SC. Special nutrition challenges: current approach to acute kidney injury. Nutr Clin Pract. 2014;29(1):56-62 PMID: 24344254 doi:10.1177/0884533613515726
  33. Sethi SK, Maxvold N, Bunchman T, Jha P, Kher V, Raina R. Nutritional management in the critically ill child with acute kidney injury: a review. Pediatr Nephrol. 2017;32(4):589-601 PMID: 27324472 doi:10.1007/s00467-016-3402-9
  34. KDOQI Work Group. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis. 2009;53(3)(suppl 2):S11-S104 PMID: 19231749 doi:10.1053/j.ajkd.2008.11.017
  35. Marlais M, Stojanovic J, Jones H, Cleghorn S, Rees L. Catch-up growth in children with chronic kidney disease started on enteral feeding after 2 years of age. Pediatr Nephrol. 2020;35(1):113-118 PMID: 31646404 doi:10.1007/s00467-019-04382-9
  36. Rees L, Jones H. Nutritional management and growth in children with chronic kidney disease. Pediatr Nephrol. 2013;28(4):527-536 PMID: 22825360 doi:10.1007/s00467-012-2258-x
  37. Yun HR, Kim H, Park JT, et al; Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) Investigators. Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis. 2018;72(3):400-410 PMID: 29728317 doi:10.1053/j.ajkd.2018.02.362
  38. Chaturvedi S, Jones C. Protein restriction for children with chronic renal failure. Cochrane Database Sys Rev. 2007: 17(4); CD006863
  39. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5)(suppl 1):S1-S290 PMID: 15114537
  40. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4)(suppl 3):S1-S153 PMID: 15806502
  41. Bhat S, Marklund M, Henry ME, et al. A systematic review of the sources of dietary salt around the world. Adv Nutr. 2020;11(3):677-686 PMID: 31904809 doi:10.1093/advances/nmz134
  42. Parekh RS, Flynn JT, Smoyer WE, et al. Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol. 2001;12(11):2418-2426 PMID: 11675418 doi:10.1681/ASN.V12112418
  43. Ulrich EH, Chanchlani R. Impact of metabolic acidosis and alkali therapy on linear growth in children with chronic kidney disease: what is the current evidence? Kidney360. 2022;3(4):590-596 PMID: 35721614 doi:10.34067/KID.0000072022
  44. Di Iorio BR, Bellasi A, Raphael KL, et al; UBI Study Group. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study. J Nephrol. 2019;32(6):989-1001 PMID: 31598912 doi:10.1007/s40620-019-00656-5
  45. Brown DD, Roem J, Ng DK, et al. Low serum bicarbonate and CKD progression in Children. Clin J Am Soc Nephrol. 2020;15(6):755-765 PMID: 32467307 doi:10.2215/CJN.07060619
  46. Denburg MR, Kumar J, Jemielita T, et al. Fracture burden and risk factors in childhood CKD: results from the CKID Cohort Study. J Am Soc Nephrol. 2016; 27(2):543-550 PMID: 26139439 doi:10.1681/ASN.2015020152
  47. Portale AA, Wolf M, Jüppner H, et al. Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol. 2014;9(2):344-353 PMID: 24311704 doi:10.2215/CJN.05840513
  48. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520-528 PMID: 15615819 doi:10.1681/ASN.2004070602
  49. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92(1):26-36 PMID: 28646995 doi:10.1016/j.kint.2017.04.006
  50. Shroff R, Wan M, Gullett A, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol. 2012;7(2):216-223 PMID: 22266572 doi:10.2215/CJN.04760511
  51. Wesseling-Perry K, Salusky IB. Chronic kidney disease: mineral and bone disorder in children. Semin Nephrol. 2013;33(2):169-179 PMID: 23465503 doi:10.1016/j.semnephrol.2012.12.017
  52. Bakkaloglu SA, Bacchetta J, Lalayiannis AD, et al; European Society for Paediatric Nephrology (ESPN) Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) and Dialysis working groups and CKD-MBD working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA. Nephrol Dial Transplant. 2021;36(3):413-425 PMID: 33245331 doi:10.1093/ndt/gfaa210
  53. Warady BA, Ng E, Bloss L, Mo M, Schaefer F, Bacchetta J. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol. 2020;35(9):1679-1697 PMID: 32367309 doi:10.1007/s00467-020-04516-4
  54. Jhee JH, Kee YK, Park S, et al. High-protein diet with renal hyperfiltration is associated with rapid decline rate of renal function: a community-based prospective cohort study. Nephrol Dial Transplant. 2020;35(1):98-106 PMID: 31172186
  55. Jankowska M, Lichodziejewska-Niemierko M, Rutkowski B, Dębska-Ślizień A, Małgorzewicz S. Water soluble vitamins and peritoneal dialysis - State of the art. Clin Nutr. 2017;36(6):1483-1489 PMID: 28089619 doi:10.1016/j.clnu.2016.12.021
  56. Joyce T, Rasmussen P, Melhem N, Clothier J, Booth C, Sinha MD. Vitamin and trace element concentrations in infants and children with chronic kidney disease. Pediatr Nephrol. 2020;35(8):1463-1470 PMID: 32291535 doi:10.1007/s00467-020-04536-0
  57. Kennedy SS, Perilloux A, Pereira RC, Handelman G, Wesseling-Perry K, Salusky IB. Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis. Pediatr Nephrol. 2021;36(2):435-441 PMID: 32772326 doi:10.1007/s00467-020-04702-4
  58. Manickavasagar B, McArdle AJ, Yadav P, et al. Hypervitaminosis A is prevalent in children with CKD and contributes to hypercalcemia. Pediatr Nephrol. 2015;30(2):317-325 PMID: 25119682 doi:10.1007/s00467-014-2916-2
  59. Paglialonga F, Consolo S, Edefonti A, Montini G. Blood pressure management in children on dialysis. Pediatr Nephrol. 2018;33(2):239-250 PMID: 28600736 doi:10.1007/s00467-017-3666-8
  60. Cupisti A, Kovesdy CP, D'Alessandro C, Kalantar-Zadeh K. Dietary approach to recurrent or chronic hyperkalemia in patients with decreased kidney function. Nutrients. 2018;10(3):261 PMID: 29495340 doi:10.3390/nu10030261
  61. Thumfart J, Puttkamer CV, Wagner S, Querfeld U, Müller D. Hemodiafiltration in a pediatric nocturnal dialysis program. Pediatr Nephrol. 2014;29(8):1411-1416 PMID: 24535110 doi:10.1007/s00467-014-2776-9
  62. Grundman JB, Wolfsdorf JI, Marks BE. Post-transplantation diabetes mellitus in pediatric patients. Horm Res Paediatr. 2020;93(9-10):510-518 PMID: 33789298 doi:10.1159/000514988
  63. Ladhani M, Lade S, Alexander SI, et al. Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death. Pediatr Nephrol. 2017;32(8):1443-1450 PMID: 28361229 doi:10.1007/s00467-017-3636-1
  64. Chaput JP, Willumsen J, Bull F, et al. 2020 WHO guidelines on physical activity and sedentary behaviour for children and adolescents aged 5-17 years: summary of the evidence. Int J Behav Nutr Phys Act. 2020;17(1):141 PMID: 33239009 doi:10.1186/s12966-020-01037-z
  65. Wesseling-Perry K, Pereira RC, Tsai E, Ettenger R, Jüppner H, Salusky IB. FGF23 and mineral metabolism in the early post-renal transplantation period. Pediatr Nephrol. 2013;28(11):2207-2215 PMID: 23852336 doi:10.1007/s00467-013-2547-z